In a new position paper, IFPMA explores some of the challenges in ensuring access to safe and quality-assured antibiotics and propose a set of policy changes for consideration.
Read moreOn 27 May 2024, IFPMA submitted a statement to the World Health Assembly on Provisional Agenda Item 11.8, Antimicrobial resistance. We are broadly supportive of the three strategic priorities described previously and welcome the newly included elevated strategic priority on effective governance and financing, which also recognizes the important role of all stakeholders, including the...
Read moreOn 15 May 2024, IFPMA delivered a statement at the UN multistakeholder hearing on antimicrobial resistance, held in New York. The hearing represented an opportunity for all stakeholders to contribute to the ongoing preparatory process for the high-level meeting on AMR, held in September 2024.
Read more